Ariz. woman sues heartburn drug makers over bone fractures 
By:
Pat Murphy
Published: December 23, 2011
Tags: acid reflux, AstraZeneca, FDA, Food and Drug Administration, Nexium, Pfizer, product liability, proton pump inhibitors
An Arizona woman has filed a product liability lawsuit alleging that she suffered bone fractures in her feet as a result of taking popular heartburn drugs made by AstraZeneca, Pfizer and other pharmaceutical companies.
Suit filed in Illinois alleges Zoloft causes birth defects
Published: December 12, 2011
Tags: Pfizer, SSRI, suicide, Zoloft
The ingestion of Zoloft during pregnancy caused birth defects in the children of eight couples, according to a lawsuit filed in Illinois state court.
Pfizer ordered to pay $72.6 million in Prempro case
Published: December 7, 2011
Tags: breast cancer, Pennsylvania, Pfizer, Prempro
Pfizer Inc. must pay $72.6 million in damages to three women who said they developed breast cancer after taking the company’s menopause drugs, a Philadelphia jury decided.
Zoloft birth defect suit filed in Ohio
Published: October 14, 2011
Tags: anti-depressants, birth defects, defective manufacturing, design defect, failure to warn, FDA, Pfizer, selective serotonin reuptake inhibitors, SSRI, Zoloft
A woman’s ingestion of the antidepressant Zoloft during pregnancy caused a fatal birth defect in her child, according to a new lawsuit filed against drug make Pfizer in Ohio state court.
Wyeth accused of using sham patents to stop generic Effexor
Published: July 13, 2011
Tags: antitrust, Effexor XR, generic drugs, patent litigation, Pfizer, Wyeth
An antitrust lawsuit filed in federal court in Mississippi alleges that Wyeth Pharmaceuticals used fraudulently obtained patents as part of a scheme to delay the introduction of generic versions of the anti-depressant Effexor XR.
Report: Chantix risks underestimated
Published: May 27, 2011
Tags: Avandia, Chantix, drug litigation, drug safety, FDA, Food and Drug Administration, Pfizer, suicide
A product liability watchdog claims that the risks of Pfizer’s quit-smoking drug Chantix have been underestimated in the latest reporting by the Food and Drug Administration.
Suit blames stop-smoking drug for killings
Published: May 11, 2011
Tags: Chantix, murder, Pennsylvania, Pfizer, suicide
The fathers of two people killed in a western Pennsylvania murder-suicide claim that a smoking cessation drug is to blame.
Pfizer said to pay $330 million in Prempro settlement
By:
Tony Ogden
Published: February 10, 2011
Tags: breast cancer, monopause, Pfizer, Prempro, prescription drug
Pfizer Inc. agreed to pay about $330 million to resolve claims that its Prempro menopause drug caused breast cancer, in the first large-scale settlements in eight years of litigation, two people familiar with the accords said.
Dilantin lawsuits turn into a mini mass tort
By:
Sylvia Hsieh
Published: February 7, 2011
Tags: Dilantin, drug litigation, epilepsy, FDA, Food and Drug Administration, Mylan, off-label uses, Pfizer, phenytoin, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
Litigation over the anti-seizure drug Dilantin has developed into a smaller-scale mass tort, with dozens of suits claiming that it causes horrendous and life-threatening skin burns.
Pfizer to pay $142.1 million over marketing of epilepsy drug
By:
Tony Ogden
Published: January 31, 2011
Tags: marketing, Neurontin, Pfizer, racketeering
Pfizer, the drug maker, has been ordered to pay a total of $142.1 million in damages for violating federal racketeering laws in the marketing of its epilepsy drug Neurontin.
SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?
If not, click here to register and learn more now.
